Anhui Huaren Health Pharmaceutical Co., Ltd. (SHE:301408)

SHE:301408 Revenue

Anhui Huaren Health Pharmaceutical had revenue of 1.49B CNY in the quarter ending September 30, 2026, with 7.31% growth. This brings the company's total for the last twelve months to 5.91B, up 14.63% year-over-year. In the year 2025, Anhui Huaren Health Pharmaceutical had annual revenue of 5.49B with 21.07% growth. That makes Anhui Huaren Health Pharmaceutical the 8,169th largest company in the world by revenue and 1,243rd in China.

• Revenue (ttm): 5.91B
• Revenue Growth: +14.63%
• P/S Ratio: 0.95
• Revenue / Employee: 661.10K
• Employees: 8,938
• Market Cap: 5.58B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Retail 4.01B 52.6%
• Pharmaceutical Marketing and Terminal Procurement 3.39B 44.6%
• Industrial Production 197.69M 2.6%
• Other 18.91M 0.2%

By Geography

Chart

• East China 4.42B 80.5%
• North-east Area 217.40M 4.0%
• Southwest Region 202.52M 3.7%
• Central China 167.53M 3.1%
• North China 159.32M 2.9%
• North-west Region 126.89M 2.3%
• Unallocated 109.08M 2.0%
• Other 88.32M 1.6%

Fiscal year ended Dec 31, 2025 See the full SHE:301408 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.49B	954.99M	21.07%
Dec 31, 2024	4.53B	734.53M	19.34%
Dec 31, 2023	3.80B	534.74M	16.39%
Jan 1, 2023	3.26B	923.72M	39.50%
Jan 1, 2022	2.34B	407.79M	21.12%

Data Source: S&P Global Market Intelligence Last updated: Oct 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error